Carmen Andreescu
University of Pittsburgh · Assistant Professor of Psychiatry
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Carmen Andreescu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:36 UTC. Open this list on ClinicalTrials.gov
- N/ANCT03577106 · A Pilot fMRI Study of TMS in Late-Life Severe WorryCarmen Andreescu · completed · Anxiety Disorders Generalized · principal investigator
- Ph4NCT03128021 · Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO)Howard Aizenstein · completed · Major Depressive Disorder · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Clinical and Translational Research Training in Geriatric Mental HealthT32MH019986 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2020 to 2026 · $371,226 awarded in 2026Same name and institution; not confirmed by an ID
- Mild Cognitive Impairment: A Prospective Community StudyR37AG023651 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2021 to 2026 · $3,831,172 awarded in 2026Same name and institution; not confirmed by an ID
- The RAW Brain - The Effect of Rumination, Anxiety and Worry on Aging and Dementia RiskR01MH108509 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2016 to 2026 · $1,514,011 awarded in 2026Same name and institution; not confirmed by an ID
- 2/3: Recurrence markers, cognitive burden and neurobiological homeostasis in late-life depression (REMBRANDT)R01MH121619 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2020 to 2024 · $840,513 awarded in 2024Same name and institution; not confirmed by an ID
- Neural Mechanisms of Monoaminergic Engagement in Late-Life Depression Treatment Response (NEMO)R01MH076079 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2017 to 2022 · $150,632 awarded in 2022Grant number is on one of their registry trials
- Functional and Structural Neuroanatomy in Late-Life Generalized Anxiety DisorderK23MH086686 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · fiscal years 2010 to 2014 · $162,076 awarded in 2014Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:36 UTC. The ranking covers the 200 most relevant of 22 PubMed records, and a shared surname and initials can bring in a namesake. All 22 on PubMed
- Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study.Br J Psychiatry · 2007142 citationsRCR 4.7
- Residual symptoms and recurrence during maintenance treatment of late-life depression.J Affect Disord · 2007117 citationsRCR 3.7
- Resting state functional connectivity and treatment response in late-life depression.Psychiatry Res · 2013112 citationsRCR 4.1
- Elevated cortisol in older adults with generalized anxiety disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram.Am J Geriatr Psychiatry · 2011103 citationsRCR 3.8
- Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy?Depress Anxiety · 200896 citationsRCR 3.4
- Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial.JAMA · 200987 citationsRCR 3.1
- Changes in neuropsychological functioning following treatment for late-life generalised anxiety disorder.Br J Psychiatry · 201175 citationsRCR 3.0
- Emotion reactivity and regulation in late-life generalized anxiety disorder: functional connectivity at baseline and post-treatment.Am J Geriatr Psychiatry · 201575 citationsRCR 3.2
- Antidepressant medication augmented with cognitive-behavioral therapy for generalized anxiety disorder in older adults.Am J Psychiatry · 201343 citationsRCR 1.9
- Treating depression to remission in older adults: a controlled evaluation of combined escitalopram with interpersonal psychotherapy versus escitalopram with depression care management.Int J Geriatr Psychiatry · 201035 citationsRCR 1.2